Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

633
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
633
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

337
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
337
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

568
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
568
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

1.5K
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Polymyalgia rheumatica-A challenge in geriatrics : Interdisciplinary presentation of diagnostics and treatment].

Zeitschrift fur Rheumatologie·2024
Same author

Acceleration and transport of relativistic electrons in the jets of the microquasar SS 433.

Science (New York, N.Y.)·2024
Same author

Final Results of GERDA on the Two-Neutrino Double-β Decay Half-Life of ^{76}Ge.

Physical review letters·2023
Same author

Search for tri-nucleon decays of <math></math>Ge in GERDA.

The European physical journal. C, Particles and fields·2023
Same author

[Polymyalgia rheumatica-A challenge in geriatrics : Interdisciplinary presentation of diagnostics and treatment].

Zeitschrift fur Gerontologie und Geriatrie·2023
Same author

Liquid argon light collection and veto modeling in GERDA Phase II.

The European physical journal. C, Particles and fields·2023
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.7K

[Dementia and comorbid conditions].

W Hofmann1

  • 1Geriatrisches Zentrum Neumünster & Bad Bramstedt, Friesenstr. 11, 24534, Neumünster, Deutschland. werner.hofmann@fek.de.

Der Internist
|January 14, 2017
PubMed
Summary
This summary is machine-generated.

Managing somatic conditions in dementia patients is crucial as causal therapies are unavailable. Treating conditions like delirium, hypertension, and diabetes can help reduce dementia symptoms.

Keywords:
Cardiovascular diseasesCholinergic antagonistsDeliriumDepressionRisk management

More Related Videos

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.4K
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

10.8K

Related Experiment Videos

Last Updated: Mar 8, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.7K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.4K
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

10.8K

Area of Science:

  • Geriatric Medicine
  • Neurology
  • Internal Medicine

Background:

  • Dementia is a prevalent issue in older adults, often lacking causal treatments.
  • Comorbid somatic conditions are common in dementia patients and significantly impact their health.
  • These conditions are often modifiable and represent key targets for intervention.

Purpose of the Study:

  • To highlight the importance of managing comorbid somatic conditions in dementia patients.
  • To emphasize the role of treating modifiable risk factors and avoiding specific medications.
  • To discuss therapeutic strategies for conditions that may exacerbate dementia symptoms.

Main Methods:

  • Review of existing literature on dementia comorbidities and management.
  • Identification of key somatic conditions relevant to dementia care.
  • Analysis of therapeutic interventions for conditions such as delirium, hypertension, heart failure, anemia, and diabetes.

Main Results:

  • Comorbid somatic conditions are prevalent and significantly influence dementia progression and symptoms.
  • Strict management of risk factors and avoidance of deliriogenic/anticholinergic drugs are essential.
  • Treatment of conditions like hypertension, diabetes, and anemia can lead to improvements in dementia symptoms.

Conclusions:

  • Addressing somatic comorbidities is a vital component of dementia care.
  • Interventions targeting modifiable conditions can alleviate dementia symptoms and improve patient outcomes.
  • Further research into integrated care models for dementia and somatic conditions is warranted.